EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for TMCI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical EPS Diluted (Quarterly) Data

View and export this data back to 2019. Start Trial.
Date Value
June 30, 2026 -0.244
March 31, 2026 -0.2781
December 31, 2025 -0.1471
September 30, 2025 -0.2564
June 30, 2025 -0.2761
March 31, 2025 -0.2541
December 31, 2024 -0.008
September 30, 2024 -0.2468
June 30, 2024 -0.3416
March 31, 2024 -0.3022
December 31, 2023 -0.1018
September 30, 2023 -0.2846
June 30, 2023 -0.1999
March 31, 2023 -0.2291
December 31, 2022 -0.0794
Date Value
September 30, 2022 -0.2189
June 30, 2022 -0.3116
March 31, 2022 -0.1648
December 31, 2021 -0.1222
September 30, 2021 -0.1216
June 30, 2021 -0.0971
March 31, 2021 -0.0506
December 31, 2020 0.047
September 30, 2020 -0.055
June 30, 2020 -0.0417
March 31, 2020 -0.0345
December 31, 2019 0.0337
September 30, 2019 -0.0558
June 30, 2019 -0.0336
March 31, 2019 -0.0401

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Tactile Systems Technology, Inc. 0.3376
Abbott Laboratories 0.5324
AngioDynamics, Inc. -0.2735
Alphatec Holdings, Inc. -0.1647
AtriCure, Inc. 0.1832